Savara to Speak at Jefferies Global Healthcare Conference

Savara Inc., a clinical stage biopharmaceutical company listed on Nasdaq under the ticker symbol SVRA, has announced that its management team will be participating in a fireside chat during the Jefferies Global Healthcare Conference. This event is scheduled for June 5, 2024, and will start at 7:00 am PT (10:00 am ET). Those interested in the discussion can access a live webcast on Savara’s official website, and the recording will be available for 90 days after the event.

Savara specializes in developing treatments for rare respiratory diseases. The company's leading program is centered on molgramostim nebulizer solution. This solution is an inhaled form of granulocyte-macrophage colony-stimulating factor (GM-CSF) and is currently in Phase 3 of its development. The treatment is being investigated specifically for autoimmune pulmonary alveolar proteinosis (aPAP), a rare lung disease. The molgramostim is administered using an investigational eFlow® Nebulizer System developed by PARI Pharma GmbH.

The management team at Savara brings extensive expertise in the fields of rare respiratory conditions and pulmonary medicine. They have demonstrated proficiency in identifying unmet medical needs and advancing product candidates through to approval and eventual commercialization. This expertise is critical in their efforts to address rare respiratory diseases, an area often overlooked in broader pharmaceutical development.

Through continued participation in significant industry conferences such as the Jefferies Global Healthcare Conference, Savara remains committed to engaging with the broader healthcare community, sharing insights, and discussing advancements in their field. This aligns with their mission of developing effective treatments for patients with rare respiratory diseases, ultimately aiming to make substantial improvements in their quality of life.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!